The Department of Health and Human Services is starting a review aimed at addressing unnecessary regulations that are hindering the Food and Drug Administration’s work.
“To make America healthy again, we have to empower our healthcare professionals to do what they excel at—preventing and treating chronic illnesses,” HHS Secretary Robert F. Kennedy stated on Tuesday. “We can’t let their skills be bogged down by red tape and excessive paperwork.”
HHS and the FDA are asking the public for input to spot outdated or unnecessary regulations that should be removed.
This initiative aligns with President Donald Trump’s executive order titled “Unleashing Prosperity Through Deregulation,” which directed each federal agency to identify ten regulations that could potentially be rescinded.
In addition, HHS will follow a “10-to-1” deregulation policy and set a limit on regulatory costs for the fiscal year 2025, requiring that the total cost of all new regulations is significantly below zero.
This directive also encompasses more than just formal regulations—it includes guidance documents, policy statements, and related directives.
In the name of transparency, HHS announced it will provide annual reports detailing estimated regulatory costs along with a list of specific rules that are being offset.
